ArticleOncology and therapy2020

Is There a Role for Multiple Lines of Anti-HER2 Therapies Administered Beyond Progression in HER2-Mutated Non-Small Cell Lung Cancer? A Case Report and Literature Review.

Giulio Metro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.